Public offering yields $115M for BioCryst By: Triangle Business Journal via Business Journals June 03, 2014 at 16:31 PM EDT Thanks to a successful public offering, Durham-based BioCryst Pharmaceuticals has some additional cash to fund accelerated testing for one of its drugs... Read More >> Related Stocks: Liberty All Star Equity Fund Piper Jaffray Companies